Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.915 USD | +5.22% | +13.31% | +35.82% |
Financials (USD)
Sales 2024 * | 325K | Sales 2025 * | 7.46M | Capitalization | 130M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -60M | EV / Sales 2024 * | 401 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 17.4 x |
P/E ratio 2024 * |
-2.09
x | P/E ratio 2025 * |
-2.44
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.42% |
Latest transcript on aTyr Pharma, Inc.
1 day | +5.22% | ||
1 week | +13.31% | ||
Current month | +21.97% | ||
1 month | +12.65% | ||
3 months | -0.52% | ||
6 months | +70.98% | ||
Current year | +35.82% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 16-03-29 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 18-07-29 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 05-09-07 |
Tim Coughlin
CHM | Chairman | 57 | 17-04-09 |
John Clarke
BRD | Director/Board Member | 70 | 05-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 1.915 | +5.22% | 489,550 |
24-05-14 | 1.82 | +7.06% | 415,503 |
24-05-13 | 1.7 | +0.59% | 4,636,559 |
24-05-10 | 1.69 | -1.74% | 224,343 |
24-05-09 | 1.72 | +1.78% | 214,054 |
Delayed Quote Nasdaq, May 15, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.82% | 130M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- LIFE Stock